Hepatic Macrophage Activation and the LPS Pathway in Patients With Alcoholic Hepatitis: A Prospective Cohort Study
- 1 November 2014
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in The American Journal of Gastroenterology
- Vol. 109 (11), 1749-1756
- https://doi.org/10.1038/ajg.2014.262
Abstract
OBJECTIVES: Inflammatory activation of resident hepatic macrophages (Kupffer cells) by portal-derived lipopolysaccharide (LPS) has a primary role in animal models of alcoholic liver disease, but it has not been systematically or longitudinally studied in human alcoholic hepatitis (AH). METHODS: We followed 50 patients with AH for 30 days. 26 patients with stable alcoholic cirrhosis and 20 healthy individuals were controls. We measured the plasma (P) concentrations of soluble CD163 (sCD163; a specific marker of inflammatory macrophage activation) and the expression of CD163 in liver tissue by immunohistochemistry and stereology of liver biopsies. We also measured the key components of the LPS pathway, P-LPS, sCD14, and LPS-binding protein (LBP), by enzyme-linked immunosorbent assay (ELISA). The 84-day mortality was registered. RESULTS: At study entry, the sCD163 concentration was 10-fold higher than in the healthy controls and 30% higher than in the stable cirrhotics (P < 0.002), and it correlated with the Glasgow Alcoholic Hepatitis, Model for End-stage Liver Disease, and Child-Pugh scores (r > 0.35, P < 0.02, all). The liver biopsies confirmed markedly increased CD163 staining (P < 0.01). P-LPS, P-CD14, and P-LBP were increased to the same degree as sCD163. During the follow-up, the sCD163 and LPS pathway components all decreased by similar to 25% (P < 0.05) but remained higher than in both control groups. sCD163 was an independent predictor of the 84-day mortality. CONCLUSIONS: The hepatic inflammation of human AH involves marked activation of hepatic macrophages, likely via the LPS pathway. Hepatic macrophages may thus present a target for biological therapy of AH.This publication has 37 references indexed in Scilit:
- Targeting the Hemoglobin Scavenger receptor CD163 in Macrophages Highly Increases the Anti-inflammatory Potency of DexamethasoneMolecular Therapy, 2012
- Clinical Significance of Soluble Hemoglobin Scavenger Receptor CD163 (sCD163) in Sepsis, a Prospective StudyPLOS ONE, 2012
- Alcoholic Liver Disease: Pathogenesis and New Therapeutic TargetsGastroenterology, 2011
- LBP/BPI proteins and their relatives: conservation over evolution and roles in mutualismBiochemical Society Transactions, 2011
- Kupffer cell activation and portal hypertensionGut, 2011
- Kupffer cells are activated in cirrhotic portal hypertension and not normalised by TIPSGut, 2011
- Susceptibility of Human Monocyte‐macrophages to Chlamydia pneumoniae Infection In Vitro is Highly Variable and Associated with levels of Soluble CD14 and C. pneumoniae IgA and Human HSP‐IgG Antibodies in SerumScandinavian Journal of Immunology, 2008
- Soluble CD163 from activated macrophages predicts mortality in acute liver failureJournal of Hepatology, 2007
- Soluble CD163 in patients with liver diseases: very high levels of soluble CD163 in patients with fulminant hepatic failureThe Esophagus, 2005
- Cellular and molecular regulation of tumor necrosis factor-alpha production by pentoxofyllineBiochemical and Biophysical Research Communications, 1988